Organic synthesis and biological evaluation of novel "3+1" mixed ligands of technetium-99m Gabapentin as receptor imaging agents

被引:6
作者
Amin, A. M. [1 ]
Abou Zid, K. [2 ]
Bayoumi, N. A. [1 ]
Abd El-hamid, M. [2 ]
机构
[1] Atom Energy Author, Labeled Cpds Dept, Hot Lab Ctr, Cairo, Egypt
[2] Ain Shams Univ, Fac Pharm, Cairo, Egypt
关键词
3+1" mixed ligands; Technetium-99m; Gabapentin; Imaging agents; TECHNETIUM COMPLEXES;
D O I
10.1007/s10967-009-0059-x
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This work focuses on the "3 + 1" mixed ligands of Tc-99m labeled Gabapentin as alpha 2 delta receptor imaging agents in the brain. Gabapentin 1-(aminomethyl) cyclohexanacetic acid as monodentate and two tridentates: tridentate A; 3-(2-imino- thiozolidin-4-one)-quinozoline-4-(3H)-one and tridentate B; N-(4-chlorophenyl)-2-imino-2H-chromene-3-Carbothioamide which were synthesized and characterized by infrared analysis (IR), H-1 nuclear magnetic resonance (NMR), and mass spectrum. Tc-99m-complexes were prepared by the "3 + 1" mixed ligand approach. The labeling conditions were optimized and the complexes was extracted by chloroform and purified by high performance liquid chromatography. Tc-99m-complexs were lipophilic and stable for at least 8-12 h at room temperature. The biodistribution of the Tc-99m-complexes was evaluated in mice. The brain uptake was 4.5% and 3.5% ID/g (percentage of the injected dose per gram) at 5 min, and the retention was 1.5% and 1.7% ID/g at 120 min for Tc-99m-complex A and Tc-99m-complex B, respectively.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 28 条
[1]   INVESTIGATIONS OF THE TECHNETIUM HYDRAZIDO CORE - SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF [(NORMAL-C4H9)4N][TC2(NNPH2)2(C6CL4O2)4].CH2CL2.2CH3OH, A TC(V)/TC(VI) CATECHOLATE COMPLEX WITH THE HYDRAZIDO LIGANDS ADOPTING THE UNUSUAL ETA-1 BRIDGING MODE [J].
ABRAMS, MJ ;
LARSEN, SK ;
ZUBIETA, J .
INORGANIC CHEMISTRY, 1991, 30 (09) :2031-2035
[2]  
Amer Kim Siarkowski, 2005, J Pediatr Nurs, V20, P119, DOI 10.1016/j.pedn.2004.12.013
[3]   Gabapentin for neuropathic cancer pain: A randomized controlled trial from the gabapentin cancer pain study group [J].
Caraceni, A ;
Zecca, E ;
Bonezzi, C ;
Arcuri, E ;
Tur, RY ;
Maltoni, M ;
Visentin, M ;
Gorni, G ;
Martini, C ;
Tirelli, W ;
Barbieri, M ;
De Conno, F .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2909-2917
[4]  
DREWS A, 2001, J LABELLED CPD RAD S, V44, P544
[5]  
GACKENHEIMER SL, 1995, J PHARMACOL EXP THER, V274, P1558
[6]   Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: Recent developments and encouraging results [J].
Hom, RK ;
Katzenellenbogen, JA .
NUCLEAR MEDICINE AND BIOLOGY, 1997, 24 (06) :485-498
[7]   Technetium(V) and rhenium(V) complexes for 5-HT2A serotonin receptor binding: Structure-affinity considerations [J].
Johannsen, B ;
Scheunemann, M ;
Spies, H ;
Brust, P ;
Wober, J ;
Syhre, R ;
Pietzsch, HJ .
NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (04) :429-438
[8]   Potential technetium small molecule radiopharmaceuticals [J].
Jurisson, SS ;
Lydon, JD .
CHEMICAL REVIEWS, 1999, 99 (09) :2205-2218
[9]  
KUNG HF, 1995, TECHNETIUM RHENIUM C, P293
[10]   Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents [J].
León, A ;
Rey, A ;
Mallo, L ;
Pirmettis, I ;
Papadopoulos, M ;
León, E ;
Pagano, M ;
Manta, E ;
Incerti, M ;
Raptopoulou, C ;
Terzis, A ;
Chiotellis, E .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (02) :217-226